MedInsights Unleashed

MedInsights Unleashed

Download on the App Store

MedInsights Unleashed episodes

  • RASolute 302: The First Major Breakthrough in Pancreatic Cancer in Decades

    The RASolute 302 trial represents a breakthrough in pancreatic cancer treatment, successfully doubling patient survival compared with standard care.

    In this episode of MedInsights Unleashed, Prof. Philip Philip, Professor of Medical Oncology, Wayne State University School of Medicine and Henry Ford Cancer Institute, discusses how targeting KRAS mutations may change the treatment landscape for pancreatic cancer, reviews the final ASCO analysis, and explains what these findings mean for patients, caregivers, and clinicians. While not a cure, the study offers new hope by extending survival, improving quality of life, and opening the door to a new era of targeted therapy research.

    43 min
  • Rethinking Advanced Thyroid Cancer: Neoadjuvant Therapy and the Future of Surgery

    In this episode of MedInsights Unleashed, John Collins speaks with Professor Gregory Randolph MD, FACS, FACE, Bertucci Chair in Thyroid Surgical Oncology at Harvard Medical School, about the evolving role of neoadjuvant therapy in advanced thyroid cancer.

    The discussion explores the challenges of locally invasive thyroid cancer and how neoadjuvant lenvatinib prior to surgery may help improve surgical outcomes, reduce morbidity, and preserve critical structures such as the recurrent laryngeal nerve.

    The conversation also highlights findings from a multicenter Phase 2 clinical trial, including promising results related to nerve preservation, vocal cord recovery, and the future of multidisciplinary thyroid cancer care.

    42 min
  • CPR, CPR-102, AEDs, and DNRs: What Everyone Should Know in an Emergency

    In this episode of MedInsights Unleashed, John Collins speaks with Devin Hinchcliffe about one of the most important life-saving interventions in medicine and emergency care — CPR.

    The discussion explores CPR fundamentals, CPR-102 updates, AED use, DNR considerations, and why rapid intervention by both healthcare professionals and members of the community can significantly improve outcomes during cardiac emergencies.

    Drawing from his experience in Emergency Medical Services, law enforcement, and EMS education, Devin provides practical insights into emergency response, first responder training, and the importance of public awareness and preparedness.

    This episode offers valuable information for healthcare professionals, caregivers, first responders, and members of the public who want a better understanding of CPR and emergency response.

    41 min
  • Beyond Aortic Valve Replacement: Understanding Flow Dynamics and the Role of DurAVR THV

    In this episode of MedInsights Unleashed, Wayne Paterson, Vice Chairman and CEO of Anteris Technologies, joins us to discuss one of the fastest evolving areas in structural heart disease — whether the future of valve replacement lies not only in replacing diseased valves, but also in restoring more natural heart flow.

    The discussion explores aortic stenosis, the evolution of TAVR, and the emerging science and MRI data surrounding DurAVR THV, including the potential importance of flow dynamics, laminar flow, durability, and long-term valve performance.

    We also discuss patient selection, future valve innovation, and how next-generation technologies may move beyond simply treating obstruction toward restoring more natural cardiovascular physiology.

    31 min
  • The Prescription Journey: What Really Happens After Your Doctor Writes the Script

    In this episode of MedInsights Unleashed, John Collins speaks with Patrick R. Coyle, MBA, about the often-overlooked journey patients face after receiving a prescription.

    The conversation explores the complex system behind drug access—including insurance coverage, copays, prior authorizations, and the role of pharmacies. Patrick provides insight into how financial and operational factors influence whether patients ultimately receive their prescribed treatment.

    The discussion also highlights key differences between branded and generic medications, the growing challenges in specialty therapies like oncology, and the importance of patient advocacy.

    This episode offers practical guidance for patients and caregivers on how to navigate the system, ask the right questions, and better understand the realities behind prescription access.

    Please find the link to Patrick R. Coyle's Website below.

    https://www.google.com/url?q=https://patrickrcoyle.com/&source=gmail&ust=1792205798695000&sa=E

    49 min
  • Rethinking Intermediate-Stage HCC: Evolution Beyond TACE as a One-Size-Fits-All Strategy

    In this episode of MedInsights Unleashed, Professor Markus Peck-Radosavljević, MD, MBA—Professor of Medicine and Chairman of the Department of Internal Medicine & Gastroenterology at Klinikum Klagenfurt, Austria— discusses evolving treatment strategies in hepatocellular carcinoma (HCC).

    The conversation explores the changing role of transarterial chemoembolization (TACE) in intermediate-stage disease, emerging clinical evidence from studies such as REPLACEMENT Emerald-1 and LEAP-012, and how new systemic and immunotherapy approaches are reshaping treatment decisions. The discussion also highlights the importance of curative opportunities, multidisciplinary care, and maintaining overall survival as the most meaningful endpoint in liver cancer treatment.

    44 min
  • When Chronic Spine Pain Becomes Surgical: Advances in Modern Spine Care

    In this episode of MedInsights Unleashed, the discussion focuses on advanced chronic spine pain and when surgery becomes part of the care pathway. Dr. Rohan R. Lall, neurosurgeon at M Health Fairview University of Minnesota Medical Center, shares clinical perspective on evolving surgical approaches for patients with severe degeneration, instability, and chronic nerve-related pain.

    The conversation explores electrically enhanced transforaminal lumbar interbody fusion (e-TLIF), which combines spinal stabilization with targeted nerve stimulation, as well as broader trends in non-opioid pain management, minimally invasive surgery, robotics, and AI shaping modern spine care.

    44 min
  • Challenging the “Good Cancer” Myth: What Patients and Clinicians Need to Know

    Dr. Lori Wirth, MD—Elizabeth and Michael Ruane Chair of Endocrine Oncology; Medical Director of the Massachusetts General Hospital Center for Head and Neck Cancers; and Professor of Medicine at Harvard Medical School—joins MedInsights Unleashed to discuss modern thyroid cancer care. She explores differentiated, medullary, and anaplastic disease; advances in diagnosis and treatment; the role of genomic testing, including BRAF V600E and RET; and the use of active surveillance for selected patients. Dr. Wirth underscores the importance of individualized care and shared decision-making, offering clear, practical insights for patients, caregivers, and clinicians navigating an evolving thyroid cancer landscape.

    57 min
  • A New Approach to Degenerative Disc Disease – Introducing Hydrafil

    In this MedInsights Unleashed episode, we explore an emerging treatment for chronic degenerative disc disease called Hydrafil.

    Our guests are Bill Niland, CEO of ReGelTec Inc., and Dr. Anthony Lowman, PhD, Professor of Biomedical Engineering and Co-Founder/Chief Medical Officer at ReGelTec. They walk us through the science, creation, and development of this injectable hydrogel technology. Hydrafil is designed to help patients with lumbar back pain by restoring hydration and pressure inside the spinal disc, supporting its structure, and potentially reducing inflammation and pain.

    ReGelTec has launched its pivotal HYDRAFIL-D Study, a multicenter, randomized U.S. trial enrolling ~225 patients. For details, visit ClinicalTrials.gov and search: Degenerative Disc Disease + Hydrafil (NCT06011551 and NCT04984629).

    32 min
  • Beyond Obesity and Oncology: How GLP1s Are Reshaping Modern Medicine

    In this episode of MedInsights Unleashed, Professor Pierre Gholam, MD., FAASLD, AGAF, returns to explore the transformative potential of GLP1-based therapies beyond diabetes and obesity. The discussion highlights how these drugs may play a groundbreaking role in **cancer prevention—particularly liver cancer—**by addressing the root causes of metabolic dysfunction, a growing public health crisis affecting millions of Americans. Prof. Gholam emphasizes the need for multidisciplinary collaboration among hepatologists, endocrinologists, and primary care providers to improve early detection and treatment of fatty liver disease through noninvasive diagnostics and proactive referral pathways. The episode also looks ahead to emerging oral and multi-agonist GLP1 therapies, marking a new frontier in personalized metabolic and oncologic care.

    50 min

About MedInsights Unleashed

From the publisher's feed

The MedInsights Unleashed Podcast aims to break down complex clinical data to provide insights from cutting-edge developments into tangible benefits for physicians, patients, and caregivers around the globe.